A study to compare the safety and efficacy of durogesic [fentanyl] with sustained release morphine in patients with cancer pain transferring from weak to strong opioids.

Trial Profile

A study to compare the safety and efficacy of durogesic [fentanyl] with sustained release morphine in patients with cancer pain transferring from weak to strong opioids.

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Aug 2009

At a glance

  • Drugs Fentanyl; Morphine
  • Indications Cancer pain
  • Focus Therapeutic Use
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 04 Aug 2009 Actual end date (Mar 2007) added as reported by ISRCTN: Current Controlled Trials.
    • 04 Aug 2009 Actual initiation date (1 Jan 1997) added as reported by ISRCTN: Current Controlled Trials.
    • 04 Aug 2009 Status changed from not stated to completed as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top